维普期刊资源整合服务平台（V6.5）

195篇 您的检索式：作者名="Nagan"

选中清除导出查看参考文献查看引证文献引用追踪共10页首页上一页第1页下一页末页 /10 跳转

	题名	作者	年代	出处	被引量
1	Gestatianal trophoblastic neoplasia mangement:an update显示文摘	Michael J Seckl	2007	Cur Opin Oncol2007，19，：	1
2	Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189显示文摘	Cheng SY Nagane M Huang HS	1997	PNAS1997，94，12：	1
3	Application of antisense ribonucleic acid complementary to O6-methylguanine-deoxyribonucleic acid methyltransferase messenger ribonucleic acid for therapy of malignant gliomas显示文摘	NAGANE M ASAI A SHIBUI S	1997	Neurosurgery1997，41，2：	1
4	Efficacy of low-dose FK506 in the treatment of Myasthenia gravis-a randomized pilot study显示文摘	Nagane Y Utsugisawa K Obara D	2005	Eur Neurol2005，53，3：	1
5	Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo显示文摘	Nagane M Pan G Weddle J	2000	Cancer Res2000，60，4：	1
6	Three types of striational antibodies in myasthenia gravis显示文摘	Suzuki S Utsugisawa K Nagane Y	2011	Auteimmune Dis2011，2011，74：	1
7	Antigen-specific T-cell activation in hyperplastic thymus in myasthenia gravis 显示文摘	Utsugisawa K Nagane Y Suzuki	2007	Music Nerve2007，36，1：	1
8	Intravesical recurrence af-ter surgical management of urothelial carcinoma of the upper urina-ry tract 显示文摘	Hirano D Okada Y Nagane Y	2012	Urol Int2012，89，1：	1
9	Antigen-specific T-cell activation in hyperplastic thymus in myasthenia gravis 显示文摘	Utsugisawa K Nagane Y Suzuki S	2007	Muscle Nerve2007，36，1：	1
10	Timing for effective application of anteriorlydirected orthopedic force to the maxilla 显示文摘	Merin D Nagan P Hagg U	1997	Am J Orthod Dentofacial Orthop1997，112，9：	1
11	Antitumor activity of the Isodon diterpenoids structural requirements for the activity显示文摘	FUJILA E NAGAN Y NODE M	1976	Experientia1976，32，2：	1
12	Classification of myas- thenia gravis based on autoantibody status显示文摘	Suzuki S Utsugisawa K Nagane Y	2007	Arch Neurol2007，64，8：	1
13	Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma 显示文摘	Kawata N Nagane Y Hirakata H	2007	Urology2007，69，：	1
14	BMD and Serum Intact Osteocalcin in Postmenopausal Osteoporosis Women显示文摘	Jagtap VR Ganu JV Nagane NS	2011	Indian J Clin Biochem2011，26，1：	1
15	Strong significant correlation between MMP-9and systemic symptoms in patients with localized renal cell carcinoma显示文摘	Kawata N Nagane Y Igarashi T	2006	Urology2006，68，3：	1
16	Development of Static and Simulation Programs for Voltage Stability Studies of Bulk Power System 显示文摘	NAGAN T TANAKA K TAKENKA K	1997	IEEE Transactions on Power Systems1997，12，1：	1
17	Efficacy of low-dose FKS06 in the treatment of myasthenia gravis--a randomized pilot study显示文摘	Nagane Y Utsugisawa K Obara D	2005	Eur Neurol2005，53，：	1
18	Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous of vascular endothelial growth factor显示文摘	Cheng SY Huang HJS Nagane M	1996	Proc Natl Acad Sci USA1996，93，16：	1
19	How do symptoms have an impact on the prognosis of renal cell carcinoma?显示文摘	KAWATA N NAGANE Y YAMAGUCHI K	2008	Int J Urol2008，15，4：	1
20	Increased death receptor 5 expression by chemOtherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor related apoptosis-inducing ligand in vitro and in vivo显示文摘	Nagane M Pan GH Weddle JJ	2000	Cancer Res2000，60，4：	1

返回顶部每页显示：

共10页首页上一页第1页下一页末页 /10 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示